Across TCGA pan-cancer cohorts, CCNI2 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated CCNI2 data layer compared with 22 for mass-spec protein.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher CCNI2 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated CCNI2 expression acts as an unfavorable survival marker.

SKCM and KIRP are the cancer types where CCNI2 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	DFS	Median	III,IV	0.058	0.613	.002	6	view →
KIRP	OS	Median	All	0.680	0.903	.038	3	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: CCNI2 tumor-vs-normal RNA expression · all CCNI2 data types